Brioni R. Moore

1.2k total citations
56 papers, 726 citations indexed

About

Brioni R. Moore is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Oncology. According to data from OpenAlex, Brioni R. Moore has authored 56 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Public Health, Environmental and Occupational Health, 9 papers in Pharmacology and 9 papers in Oncology. Recurrent topics in Brioni R. Moore's work include Malaria Research and Control (38 papers), Mosquito-borne diseases and control (14 papers) and Drug Transport and Resistance Mechanisms (9 papers). Brioni R. Moore is often cited by papers focused on Malaria Research and Control (38 papers), Mosquito-borne diseases and control (14 papers) and Drug Transport and Resistance Mechanisms (9 papers). Brioni R. Moore collaborates with scholars based in Australia, Papua New Guinea and Spain. Brioni R. Moore's co-authors include Kevin T. Batty, Timothy M. E. Davis, Madhu Page‐Sharp, Sam Salman, Ivo Müeller, John Benjamin, Kenneth F. Ilett, Laurens Manning, Leanne J. Robinson and Moses Laman and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Brioni R. Moore

51 papers receiving 712 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brioni R. Moore Australia 17 540 144 95 84 82 56 726
S Krudsood Thailand 21 614 1.1× 150 1.0× 111 1.2× 155 1.8× 79 1.0× 32 826
Daniel Blessborn United Kingdom 17 646 1.2× 234 1.6× 185 1.9× 86 1.0× 94 1.1× 28 882
Borimas Hanboonkunupakarn Thailand 20 630 1.2× 122 0.8× 93 1.0× 125 1.5× 168 2.0× 63 995
Anyirékun Fabrice Somé Burkina Faso 13 481 0.9× 148 1.0× 88 0.9× 87 1.0× 88 1.1× 44 609
Christine Manyando Zambia 13 699 1.3× 133 0.9× 71 0.7× 117 1.4× 161 2.0× 23 914
Lucy Phaiphun United Kingdom 9 692 1.3× 206 1.4× 154 1.6× 106 1.3× 121 1.5× 9 760
Manoranjan Ranjit‬ India 18 551 1.0× 83 0.6× 68 0.7× 132 1.6× 113 1.4× 84 959
Eric M. Njunju Zambia 7 547 1.0× 133 0.9× 128 1.3× 99 1.2× 97 1.2× 10 624
Podjanee Jittamala Thailand 19 660 1.2× 191 1.3× 119 1.3× 125 1.5× 125 1.5× 38 1.1k
Myaing M. Nyunt United States 18 711 1.3× 165 1.1× 89 0.9× 165 2.0× 101 1.2× 35 879

Countries citing papers authored by Brioni R. Moore

Since Specialization
Citations

This map shows the geographic impact of Brioni R. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brioni R. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brioni R. Moore more than expected).

Fields of papers citing papers by Brioni R. Moore

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brioni R. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brioni R. Moore. The network helps show where Brioni R. Moore may publish in the future.

Co-authorship network of co-authors of Brioni R. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of Brioni R. Moore. A scholar is included among the top collaborators of Brioni R. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brioni R. Moore. Brioni R. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Birru, Eshetie Melese, Kevin T. Batty, Laurens Manning, Stephanie Enkel, & Brioni R. Moore. (2025). Acceptability and Implementation Challenges of Benzathine Penicillin G Secondary Prophylaxis for Rheumatic Heart Disease in Ethiopia: A Qualitative Study. Global Heart. 20(1). 8–8.
2.
Bennett, Julie, Sam Salman, Hazel Dobinson, et al.. (2025). High dose, subcutaneous injections of benzathine penicillin G (SCIP) to prevent rheumatic fever: A single arm, phase IIa trial of safety and pharmacokinetics. Journal of Infection. 91(1). 106506–106506. 1 indexed citations
3.
4.
Kado, Joseph, Sam Salman, Stephanie Enkel, et al.. (2023). Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study. Antimicrobial Agents and Chemotherapy. 67(12). e0096223–e0096223. 14 indexed citations
5.
Unger, Holger W., Anna Maria van Eijk, Georgia R. Gore‐Langton, et al.. (2023). The effect and control of malaria in pregnancy and lactating women in the Asia-Pacific region. The Lancet Global Health. 11(11). e1805–e1818. 9 indexed citations
6.
Timinao, Lincoln, Lina Lorry, Ádám Butykai, et al.. (2021). Magneto-optical diagnosis of symptomatic malaria in Papua New Guinea. Nature Communications. 12(1). 969–969. 25 indexed citations
7.
Manning, Laurens, et al.. (2021). Antimalarials for children with Plasmodium vivax infection: Current status, challenges, and research priorities. Parasitology International. 87. 102512–102512. 6 indexed citations
8.
Ketema, Ezra B., Abraha Hailu, Madhu Page‐Sharp, et al.. (2021). High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease. PLoS neglected tropical diseases. 15(6). e0009399–e0009399. 9 indexed citations
9.
Moore, Brioni R. & Timothy M. E. Davis. (2020). Updated pharmacokinetic considerations for the use of antimalarial drugs in pregnant women. Expert Opinion on Drug Metabolism & Toxicology. 16(9). 741–758. 5 indexed citations
10.
Moore, Brioni R., John Benjamin, Maria Ome‐Kaius, et al.. (2019). A Randomized Open-Label Evaluation of the Antimalarial Prophylactic Efficacy of Azithromycin-Piperaquine versus Sulfadoxine-Pyrimethamine in Pregnant Papua New Guinean Women. Antimicrobial Agents and Chemotherapy. 63(10). 12 indexed citations
11.
Millat-Martínez, Pere, Moses Laman, Leanne J. Robinson, et al.. (2018). Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration. Antimicrobial Agents and Chemotherapy. 62(12). 5 indexed citations
12.
Moore, Brioni R., et al.. (2017). Artemisinin Therapy for Malaria in Hemoglobinopathies: A Systematic Review. Clinical Infectious Diseases. 66(5). 799–804. 5 indexed citations
13.
Moore, Brioni R., Moses Laman, Sam Salman, et al.. (2016). Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy. Drugs. 76(7). 789–804. 17 indexed citations
14.
Laman, Moses, John Benjamin, Brioni R. Moore, et al.. (2015). Artemether-lumefantrine versus artemisinin-naphthoquine in Papua New Guinean children with uncomplicated malaria: a six months post-treatment follow-up study. Malaria Journal. 14(1). 121–121. 9 indexed citations
15.
Davis, Timothy M. E., Brioni R. Moore, Sam Salman, et al.. (2015). Use of quantitative pharmacology tools to improve malaria treatments. Expert Review of Clinical Pharmacology. 9(2). 303–316. 3 indexed citations
16.
Laman, Moses, Brioni R. Moore, John Benjamin, et al.. (2014). Artemisinin-Naphthoquine versus Artemether-Lumefantrine for Uncomplicated Malaria in Papua New Guinean Children: An Open-Label Randomized Trial. PLoS Medicine. 11(12). e1001773–e1001773. 35 indexed citations
17.
Patel, Kashyap, et al.. (2014). Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model. Journal of Antimicrobial Chemotherapy. 69(8). 2155–2163. 14 indexed citations
18.
Patel, Kashyap, et al.. (2012). Mechanism-Based Model of Parasite Growth and Dihydroartemisinin Pharmacodynamics in Murine Malaria. Antimicrobial Agents and Chemotherapy. 57(1). 508–516. 22 indexed citations
19.
Batty, Kevin T., Brioni R. Moore, Kenneth F. Ilett, et al.. (2009). Investigation of reproductive toxicity of piperaquine in mice. Reproductive Toxicology. 29(2). 206–213. 10 indexed citations
20.
Batty, Kevin T., Brioni R. Moore, Kenneth F. Ilett, et al.. (2008). Toxicology and pharmacokinetics of piperaquine in mice. Toxicology. 249(1). 55–61. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S Krudsood Breakdown of academic impact, for papers by Daniel Blessborn Breakdown of academic impact, for papers by Borimas Hanboonkunupakarn Breakdown of academic impact, for papers by Anyirékun Fabrice Somé Breakdown of academic impact, for papers by Christine Manyando Breakdown of academic impact, for papers by Lucy Phaiphun Breakdown of academic impact, for papers by Manoranjan Ranjit‬ Breakdown of academic impact, for papers by Eric M. Njunju Breakdown of academic impact, for papers by Podjanee Jittamala Breakdown of academic impact, for papers by Myaing M. Nyunt
Rankless by CCL
2026